Tonix Pharmaceuticals Holding Corp. (TNXP) Capital expenditures 2016–2025
Tonix Pharmaceuticals Holding Corp. (TNXP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$3.4MFY2025 · since FY2016: $66,000 → $3.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.4M | +2707.5% |
| FY2024 | $120,000 | -98.5% |
| FY2023 | $7.9M | -83.6% |
| FY2022 | $48.1M | +36.4% |
| FY2021 | $35.3M | +312.3% |
| FY2020 | $8.6M | +50276.5% |
| FY2019 | $17,000 | +183.3% |
| FY2018 | $6,000 | +20.0% |
| FY2017 | $5,000 | -92.4% |
| FY2016 | $66,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice